|
|
Post by joshuabohinc on Feb 23, 2021 22:45:53 GMT -5
This was posted on LinkedIn by Mannkind IT Project manager today and reposted by Mike. Seems like a big deal, either super confident on $UTHR sales (we failed at that projection for afrezza first time) or manufacturing for covid vaccine/therapy (Regeneron?). To my knowledge, they haven’t mentioned before need for expansion, just that they had done capital improvements already on one line and could expand if needed with limited cost to change to $uthr type line.
“MannKind Corp will be significantly expanding its Research and Manufacturing Facility in Danbury, CT and we need a talented staffing professional to lead talent acquisition, onboarding, and orientation for this critically important site. Please check out this job or forward it on to potential candidates. This and other great jobs are also posted on http://www.mannkindcorp.com.”
|
|
|
|
Post by goyocafe on Feb 23, 2021 22:50:02 GMT -5
This was posted on LinkedIn by Mannkind IT Project manager today and reposted by Mike. Seems like a big deal, either super confident on $UTHR sales (we failed at that projection for afrezza first time) or manufacturing for covid vaccine/therapy (Regeneron?). To my knowledge, they haven’t mentioned before need for expansion, just that they had done capital improvements already on one line and could expand if needed with limited cost to change to $uthr type line. “MannKind Corp will be significantly expanding its Research and Manufacturing Facility in Danbury, CT and we need a talented staffing professional to lead talent acquisition, onboarding, and orientation for this critically important site. Please check out this job or forward it on to potential candidates. This and other great jobs are also posted on http://www.mannkindcorp.com.” What the hell is Stuart Tross doing? |
|
|
|
Post by joshuabohinc on Feb 23, 2021 22:52:48 GMT -5
World’s Best Tross!
|
|
|
|
Post by hellodolly on Feb 24, 2021 6:28:08 GMT -5
This was posted on LinkedIn by Mannkind IT Project manager today and reposted by Mike. Seems like a big deal, either super confident on $UTHR sales (we failed at that projection for afrezza first time) or manufacturing for covid vaccine/therapy (Regeneron?). To my knowledge, they haven’t mentioned before need for expansion, just that they had done capital improvements already on one line and could expand if needed with limited cost to change to $uthr type line. “MannKind Corp will be significantly expanding its Research and Manufacturing Facility in Danbury, CT and we need a talented staffing professional to lead talent acquisition, onboarding, and orientation for this critically important site. Please check out this job or forward it on to potential candidates. This and other great jobs are also posted on http://www.mannkindcorp.com.” Interesting. Either way, seems to indicate some positive momentum for the MNKD story. |
|
|
|
Post by mango on Feb 24, 2021 8:31:16 GMT -5
$MNKD
‼️Oppenheimer raises price target to $7
‼️BTIG raises price target to $8
✅ Tyvaso DPI FDA approval this year
✅ Sumatripan Phase 1 this year
✅ Clofazimine Phase 1 this year
✅ Royalties from Thyquidity Co-Promote w/ Vertice Pharma starts NOW
✅ 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021 at 9:00 am (ET)
✅ 2021 SVB Leerink Global Healthcare Conference—Thursday, February 25, 2021 at 1:00 pm (ET)
We’re just getting started folks—stay tuned
|
|
|
|
Post by factspls88 on Feb 24, 2021 10:48:22 GMT -5
This was posted on LinkedIn by Mannkind IT Project manager today and reposted by Mike. Seems like a big deal, either super confident on $UTHR sales (we failed at that projection for afrezza first time) or manufacturing for covid vaccine/therapy (Regeneron?). To my knowledge, they haven’t mentioned before need for expansion, just that they had done capital improvements already on one line and could expand if needed with limited cost to change to $uthr type line. “MannKind Corp will be significantly expanding its Research and Manufacturing Facility in Danbury, CT and we need a talented staffing professional to lead talent acquisition, onboarding, and orientation for this critically important site. Please check out this job or forward it on to potential candidates. This and other great jobs are also posted on http://www.mannkindcorp.com.” Is your comment about Regeneron and hope/guess or is it based on fact? I know that the emergency use of the monoclonal antibody that Trump has been slow because it requires the patient to have Covid and, as I understand it, is given intravenously. Conversion to technosphere could be a huge win for Mnkd. The mrna technology is not a one shot deal. It is the future in my opinion. |
|
|
|
Post by uvula on Feb 25, 2022 15:58:58 GMT -5
This thread was from almost exactly 1 year ago. Perhaps the 30 people were part of this expansion?
|
|
